opzelura™ (ruxolitinib) Creme
Opzelura (ruxolitinib) is a prescription cream used on the skin (topical) to treat mild to moderate eczema (atopic dermatitis) in patients 12 years or older who aren’t suitable for or have failed other topical prescription drugs.
Eligibility requirements:
- *See Additional Information section below
- Between 400-500% of FPL
- FDA Approved Diagnosis – See Program Website for Details
- Must reside and receive treatment in US
- *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
Applicable drugs:
- Opzelura (ruxolitinib) Cream; Topical
Provider: IncyteCARES for Opzelura Patient Assistance Program
Eligibility requirements:
- Must have no prescription coverage for needed medication
- At or below 400% of FPL
- FDA-approved diagnosis
- Must be residing in the US or Puerto Rico
- Co-payment assistance, and patient assistance programs are available for eligible patients.
Applicable drugs:
- Opzelura (ruxolitinib) Cream; Topical
Reviews
There are no reviews yet.